- Home
- RLAY vs MNTSW Comparison
RLAY vs MNTSW Comparison
Compare RLAY & MNTSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | MNTSW |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | 123 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | N/A |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RLAY | MNTSW |
|---|---|---|
| Price | $10.36 | $0.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $15.67 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 129.3K |
| Earning Date | 05-27-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $396.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $1.78 | $0.01 |
| 52 Week High | $11.49 | $0.10 |
Technical Indicators
Market Signals| Indicator | RLAY | MNTSW |
|---|---|---|
| Relative Strength Index (RSI) | 60.91 | 45.65 |
| Support Level | $9.06 | $0.01 |
| Resistance Level | $11.43 | $0.03 |
| Average True Range (ATR) | 0.77 | 0.00 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 56.56 | 15.42 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About MNTSW Momentus Inc.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.